Figure 2.

Morphological changes of liver in control-group (A, C) and MS-275-group at high dosage (B, D) (A, B hematoxylin-eosin, ×40; C, D hematoxylin-eosin, ×100).

Morphological changes of liver in control-group (A, C) and MS-275-group at high dosage (B, D) (A, B hematoxylin-eosin, ×40; C, D hematoxylin-eosin, ×100).